Literature DB >> 3128419

Changes in jejunal permeability and passive permeation of sugars in intestinal biopsies in coeliac disease and Crohn's disease.

D J Dawson1, R W Lobley, P C Burrows, J A Notman, M Mahon, R Holmes.   

Abstract

1. The relative effects of changes in mucosal surface area and mucosal permeability on the passive uptakes of mannitol and raffinose have been studied in vitro using jejunal biopsies from 48 controls, 32 patients with coeliac disease and 11 patients with Crohn's disease. Total mucosal permeation was corrected for surface area measured morphometrically to provide an index of mucosal permeability. 2. In untreated coeliac disease, permeation of mannitol was reduced by 35% (P = 0.006) and that of raffinose was increased by 66% (P = 0.0095) compared with controls, whereas mucosal permeability to mannitol was increased twofold (P = 0.009) and to raffinose fivefold (P = 0.0001). Mucosal permeability was similar for each sugar. 3. In treated coeliac disease, permeation and permeability for mannitol were normal, but remained elevated for raffinose by 23% (P = 0.036) and 41% (P = 0.024), respectively. 4. In Crohn's disease, permeation of mannitol was reduced by 21%, but that of raffinose and mucosal permeability to both sugars were normal. 5. These findings suggest that surface area is quantitatively more important than mucosal permeability in determining the total permeation of mannitol, while the converse is true for raffinose. The findings are compatible with paracellular uptake of raffinose, but with both paracellular and transcellular uptake of mannitol. Both pathways are affected in coeliac disease, whereas only transcellular uptake is affected in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128419     DOI: 10.1042/cs0740427

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs.

Authors:  E J Hall; R M Batt
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

2.  Mucosal permeability testing: should interpretation change or stay the same?

Authors:  D S Rafati; R J Shulman
Journal:  Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 3.598

3.  Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease.

Authors:  K Teahon; S Somasundaram; T Smith; I Menzies; I Bjarnason
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

4.  Is the sugar intestinal permeability test a reliable investigation for coeliac disease screening?

Authors:  C Catassi; E Fabiani; I M Rätsch; A Bonucci; M Dotti; G V Coppa; P L Giorgi
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

5.  A pilot study of fluticasone propionate in untreated coeliac disease.

Authors:  H C Mitchison; H al Mardini; S Gillespie; M Laker; A Zaitoun; C O Record
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

6.  Identification of metabolic signatures linked to anti-inflammatory effects of Faecalibacterium prausnitzii.

Authors:  Sylvie Miquel; Marion Leclerc; Rebeca Martin; Florian Chain; Marion Lenoir; Sébastien Raguideau; Sylvie Hudault; Chantal Bridonneau; Trent Northen; Benjamin Bowen; Luis G Bermúdez-Humarán; Harry Sokol; Muriel Thomas; Philippe Langella
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

7.  Searching for the Bacterial Effector: The Example of the Multi-Skilled Commensal Bacterium Faecalibacterium prausnitzii.

Authors:  Rebeca Martín; Luis G Bermúdez-Humarán; Philippe Langella
Journal:  Front Microbiol       Date:  2018-03-06       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.